Design Therapeutics Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Design therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Design Therapeutics Daily Today - Breaking & Trending Today

Design Therapeutics (NASDAQ:DSGN) Rating Increased to Overweight at Piper Sandler

Design Therapeutics (NASDAQ:DSGN) Rating Increased to Overweight at Piper Sandler
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Johnp Schmid , Piper Sandler , Hermes Inc , Securities Exchange Commission , Royal Bank , Nisa Investment Advisors , Simplicity Wealth , Design Therapeutics Inc , Bleakley Financial Group , Design Therapeutics , Get Free Report , Director John , Exchange Commission , Fire Capital , Investment Advisors , Design Therapeutics Daily ,

Design Therapeutics, Inc. (NASDAQ:DSGN) Director Purchases $66,605.66 in Stock

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid purchased 17,809 shares of Design Therapeutics stock in a transaction dated Monday, March 25th. The shares were bought at an average price of $3.74 per share, with a total value of $66,605.66. Following the completion of the acquisition, the director now directly owns […] ....

United States , Johnp Schmid , Securities Exchange Commission , Group Plc , Nisa Investment Advisors , Design Therapeutics Inc , Tower Research Capital , Royal Bank , Design Therapeutics Company Profile , Hermes Inc , Design Therapeutics , Get Free Report , Director John , Exchange Commission , Fire Capital , Investment Advisors , Research Capital , General Group Plc , Design Therapeutics Daily , Nasdaq Dsgn , Insider Trading , Nsider Trades ,

John P. Schmid Acquires 9,156 Shares of Design Therapeutics, Inc. (NASDAQ:DSGN) Stock

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid acquired 9,156 shares of Design Therapeutics stock in a transaction on Friday, March 22nd. The stock was acquired at an average cost of $3.62 per share, for a total transaction of $33,144.72. Following the completion of the purchase, the director now owns 9,156 […] ....

United States , Johnp Schmid , Design Therapeutics Company Profile , Tower Research Capital , Securities Exchange Commission , Hermes Inc , Group Plc , Royal Bank , Nisa Investment Advisors , Design Therapeutics Inc , Design Therapeutics , Get Free Report , Director John , Exchange Commission , Fire Capital , Investment Advisors , Research Capital , General Group Plc , Design Therapeutics Daily , Nasdaq Dsgn , Insider Trading , Nsider Trades ,

Insider Buying: Design Therapeutics, Inc. (NASDAQ:DSGN) Director Purchases 9,156 Shares of Stock

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid bought 9,156 shares of the company’s stock in a transaction on Friday, March 22nd. The stock was purchased at an average cost of $3.62 per share, with a total value of $33,144.72. Following the completion of the transaction, the director now owns 9,156 […] ....

United States , Johnp Schmid , America Corp , Design Therapeutics Inc , Manufacturers Life Insurance Company , Tower Research Capital , Royal Bank , Group Plc , American International Group Inc , Design Therapeutics , Get Free Report , Director John , General Group Plc , International Group , Research Capital , Design Therapeutics Daily , Nasdaq Dsgn , Insider Trading , Nsider Trades ,

Design Therapeutics, Inc. (NASDAQ:DSGN) Director John P. Schmid Acquires 17,809 Shares

Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) Director John P. Schmid acquired 17,809 shares of the company’s stock in a transaction that occurred on Monday, March 25th. The stock was purchased at an average price of $3.74 per share, for a total transaction of $66,605.66. Following the purchase, the director now owns 26,965 shares […] ....

United States , Nova Scotia , Johnp Schmid , Design Therapeutics Company Profile , Royal Bank , Securities Exchange Commission , Capital Management , Goldman Sachs Group Inc , Blackrock Inc , Design Therapeutics Inc , Design Therapeutics , Get Free Report , Director John , Exchange Commission , Therapeutics Trading Down , Sachs Group , State Street Corp , Street Corp , Design Therapeutics Daily ,